Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Poole

Showing results (781-790 of 1,035) with videos related to

Pageof 104
Sort By:
Macromolecular Bioscience|February 21, 2012
Conductive hydrogels: mechanically robust hybrids for use as biomaterialsRylie A Green, Rachelle T Hassarati, Josef A Goding, et al.
European Heart Journal|April 23, 1999
Incidence and aetiology of heart failure; a population-based studyM R Cowie, D A Wood, A J Coats, et al.
British Heart Journal|July 1, 1995
Insulin resistance syndrome in postmenopausal women with cardiological syndrome XI F Godsland, D Crook, J C Stevenson, et al.
American Journal of Cardiac Imaging|December 1, 1993
Validation of measurement of regional myocardial perfusion in humans by ultrafast x-ray computed tomographyP F Ludman, A J Coats, P Burger, et al.
Journal of Cardiac Failure|May 30, 2009
Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failureEwa A Jankowska, Gerasimos Filippatos, Beata Ponikowska, et al.
European Heart Journal|February 1, 1997
The epidemiology of heart failureM R Cowie, A Mosterd, D A Wood, et al.
European Heart Journal|February 1, 1997
The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failureS D Anker, J W Swan, M Volterrani, et al.
QJM : Monthly Journal of the Association of Physicians|May 30, 1998
Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failureS D Anker, M Volterrani, K R Egerer, et al.
European Heart Journal|September 22, 1998
Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic SystemJ Lubsen, P A Poole-Wilson, S J Pocock, et al.
Nature Chemistry|May 12, 2025
Exo-templating via pseudorotaxane formation reduces pathway complexity in the multicomponent self-assembly of M<sub>12</sub>L<sub>24</sub> nanospheresT Bouwens, E O Bobylev, L S D Antony, et al.
Pageof 104

Showing results (781-790 of 1,035) with videos related to

Sort By:
Pageof 104
Macromolecular Bioscience|February 21, 2012
Conductive hydrogels: mechanically robust hybrids for use as biomaterialsRylie A Green, Rachelle T Hassarati, Josef A Goding, et al.
European Heart Journal|April 23, 1999
Incidence and aetiology of heart failure; a population-based studyM R Cowie, D A Wood, A J Coats, et al.
British Heart Journal|July 1, 1995
Insulin resistance syndrome in postmenopausal women with cardiological syndrome XI F Godsland, D Crook, J C Stevenson, et al.
American Journal of Cardiac Imaging|December 1, 1993
Validation of measurement of regional myocardial perfusion in humans by ultrafast x-ray computed tomographyP F Ludman, A J Coats, P Burger, et al.
Journal of Cardiac Failure|May 30, 2009
Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failureEwa A Jankowska, Gerasimos Filippatos, Beata Ponikowska, et al.
European Heart Journal|February 1, 1997
The epidemiology of heart failureM R Cowie, A Mosterd, D A Wood, et al.
European Heart Journal|February 1, 1997
The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failureS D Anker, J W Swan, M Volterrani, et al.
QJM : Monthly Journal of the Association of Physicians|May 30, 1998
Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failureS D Anker, M Volterrani, K R Egerer, et al.
European Heart Journal|September 22, 1998
Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic SystemJ Lubsen, P A Poole-Wilson, S J Pocock, et al.
Nature Chemistry|May 12, 2025
Exo-templating via pseudorotaxane formation reduces pathway complexity in the multicomponent self-assembly of M<sub>12</sub>L<sub>24</sub> nanospheresT Bouwens, E O Bobylev, L S D Antony, et al.
Pageof 104